Patient Summary

Diagnosis

1. Enteric Fever (Typhoid Fever) - PRIMARY DIAGNOSIS

• S. Typhi "O" titre positive up to 1:80 - this is the more diagnostically significant antigen (active infection marker). A titre of ≥1:80 is considered significant in most endemic settings.
• S. Typhi "H" positive only up to 1:40 - may represent past infection or a response to vaccination.
• Paratyphi A and B: all negative - rules out paratyphoid fever.
• Conclusion: Positive Widal consistent with active typhoid fever (S. Typhi infection)

Important caveat: The Widal test has limited sensitivity (~56%) and specificity. False positives occur in endemic areas from past infections, other Salmonella infections, or cross-reactions. Confirmation with blood culture (most sensitive in week 1) is the gold standard. As Harrison's Principles (2025) states, blood culture during the first week, urine/stool culture in the second week, or bone marrow culture (most sensitive, even post-antibiotics) should be performed when possible.

2. Severe Microcytic Hypochromic Anemia - CONCURRENT DIAGNOSIS

• Hb of 6.0 g/dL = severe anemia requiring urgent attention
• Low MCV (72.8) + low RBC + elevated RDW = microcytic anemia with anisocytosis
• Most likely: Iron deficiency anemia (IDA) - the most common cause in a 45-year-old woman in this region (menstrual losses, dietary deficiency)
• The typhoid infection itself may worsen anemia through hemolysis, bone marrow suppression, and GI blood loss
• Mild leukocytosis (11,200) is consistent with an active bacterial infection; note that classic typhoid may show leukopenia, but elevated WBC can occur especially with secondary infection or abscess
• Mildly elevated monocytes support ongoing infectious/inflammatory process

Treatment & Management

A. Antibiotic Treatment for Typhoid Fever

Critical note for India: Fluoroquinolone (ciprofloxacin) resistance is high in South Asia - strains with decreased susceptibility to ciprofloxacin are now dominant. Ceftriaxone IV or Azithromycin oral should be preferred, especially if the patient does not defervesce within 72 hours of fluoroquinolone therapy - Harrison's 22E, p. 1361.

• Add dexamethasone 3 mg/kg IV loading dose, then 1 mg/kg q6h for 48 hours (in addition to antibiotics) - reduces mortality in severe typhoid.
• IV fluid resuscitation

B. Treatment of Severe Anemia (Hb 6.0 g/dL)

• Hb < 7 g/dL with symptoms (fatigue, tachycardia, breathlessness) typically warrants packed red cell transfusion
• If hemodynamically stable and asymptomatic, oral iron supplementation alone may suffice but will take weeks to correct

• Ferrous sulfate 200 mg (elemental iron ~65 mg) three times daily, between meals
• Vitamin C (250-500 mg) with each dose to enhance absorption
• Continue for 3-6 months after Hb normalizes to replenish iron stores
• As [Guyton & Hall Textbook of Medical Physiology] notes, in iron deficiency "the intestines absorb as much iron as possible" but may not meet demand, requiring supplementation

• Dietary history
• Menstrual history (heavy periods?)
• Stool for occult blood (GI blood loss)
• Serum ferritin, serum iron, TIBC (to confirm IDA)
• Peripheral blood smear

• Increase intake of iron-rich foods: red meat, leafy greens, beans, fortified cereals
• Avoid tea/coffee with meals (inhibit iron absorption)

Monitoring & Follow-up

Summary of Active Problems

1. Typhoid fever - treat with Ceftriaxone IV (2g/day x 10-14 days) or Azithromycin oral (1g/day x 5-10 days). Avoid relying on ciprofloxacin alone given regional resistance patterns.
2. Severe iron deficiency anemia (Hb 6.0 g/dL) - evaluate need for transfusion; start oral iron supplementation; investigate underlying cause.
3. Mild leukocytosis - likely reactive to typhoid infection; monitor for complications (intestinal perforation, abscess, secondary sepsis).
4. Bilirubin normal - hepatic function preserved at this stage; recheck if patient develops jaundice.

Disclaimer: This analysis is for educational/informational purposes. Treatment decisions must be made by the treating physician based on clinical examination, local antibiogram/susceptibility data, and the patient's full clinical picture.